Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4634683 | 0.82 | KDM4E (0.45) | DRD3 | |
| SCHEMBL11392579 | 0.77 | — | — | |
| SCHEMBL19466474 | 0.77 | — | — | |
| SCHEMBL11213803 | 0.77 | — | — | |
| SCHEMBL27814512 | 0.76 | EBP (0.47) | DRD3 | |
| Hydrochloric Acid SCHEMBL3131967 | 0.75 | DRD4 (0.43) | DRD3 | |
| SCHEMBL1828412 | 0.74 | — | — | |
| SCHEMBL19466478 | 0.74 | DRD3 (0.31) | DRD3 | |
| SCHEMBL8656820 | 0.72 | — | — | |
| SCHEMBL20570593 | 0.72 | DRD3 (0.30) | DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050261498-A1 | Preparation of 4-amino-1-naphthol ethers | KOMOSCHINSKI JOACHIM | 2005-11-24 | — | — | US | disclosed |
| US-6964963-B2 | Preparation of 4-amino-1-naphthol ethers | BAYER AKTIENGESELLSCHAFT (DE) | 2005-11-15 | — | — | US | disclosed |
| US-20030083525-A1 | Preparation of 4-amino-1-naphthol ethers | LANXESS DEUTSCHLAND GMBH (DE) | 2003-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261498-A1 | Preparation of 4-amino-1-naphthol ethers | NAP1L4, NAAA, NPEPPS | DRD3 1514/4885 |
| US-20030083525-A1 | Preparation of 4-amino-1-naphthol ethers | NAP1L4, NAAA, NPEPPS | DRD3 1514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.